Ketamine induces rapid and sustained antidepressant-like effects in chronic pain induced depression: Role of MAPK signaling pathway.

Progress in Neuro-psychopharmacology & Biological Psychiatry
Muris HumoIpek Yalcin


Chronic pain produces psychologic distress, which often leads to mood disorders such as depression. Co-existing chronic pain and depression pose a serious socio-economic burden and result in disability affecting millions of individuals, which urges the development of treatment strategies targeting this comorbidity. Ketamine, a noncompetitive antagonist of the N-methyl-d-aspartate (NMDA) receptor, is shown to be efficient in treating both pain and depression-related symptoms. However, the molecular characteristics of its role in chronic pain-induced depression remain largely unexplored. Hence, we studied the behavioral and molecular effects of a single systemic administration of ketamine (15 mg/kg, i.p.) on mechanical hypersensitivity and depressive-like consequences of chronic neuropathic pain. We showed that ketamine transiently alleviated mechanical hypersensitivity (lasting <24 h), while its antidepressant effect was observed even 72 h after administration. In addition, ketamine normalized the upregulated expression of the mitogen activated protein kinase (MAPK) phosphatase 1 (MKP-1) and the downregulated phosphorylation of extracellular signal-regulated kinase (pERK) in the anterior cingulate cortex (ACC) of mice displaying...Continue Reading


Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y I ShelineM W Vannier
Jan 10, 1997·The Journal of Biological Chemistry·J M BrondelloF R McKenzie
Feb 25, 2000·Biological Psychiatry·R M BermanJ H Krystal
Dec 7, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Wayne C DrevetsMarcus E Raichle
May 20, 2003·Journal of Neurochemistry·S D KuipersG J Ter Horst
May 1, 1965·Clinical Pharmacology and Therapeutics·E F DOMINOG CORSSEN
Sep 23, 2003·Anesthesia and Analgesia·Andrei B PetrenkoKoki Shimoji
Nov 12, 2003·Archives of Internal Medicine·Matthew J BairKurt Kroenke
Nov 25, 2003·Anesthesia and Analgesia·Graham Hocking, Michael J Cousins
Nov 4, 2004·Biological Psychiatry·Craig A StockmeierGrazyna Rajkowska
May 6, 2005·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Shiro KoizukaFumio Goto
Jun 22, 2005·The Journal of Biological Chemistry·Elisa A Waxman, David R Lynch
Mar 24, 2006·Psychosomatic Medicine·Bruce A ArnowChris Hayward
Aug 9, 2006·Archives of General Psychiatry·Carlos A ZarateHusseini K Manji
May 3, 2007·Nature Reviews. Drug Discovery·Kate L JeffreyCharles R Mackay
Jul 13, 2007·The International Journal of Neuropsychopharmacology·Zubin BhagwagarPhilip J Cowen
Jan 20, 2009·Brain Research Reviews·Ru-Rong JiGary R Strichartz
Mar 13, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hong CaoYu-Qiu Zhang
Jun 24, 2009·Journal of Clinical Pharmacology·Filippia AroniTheodoros Xanthos
Nov 3, 2009·Psychiatric Services : a Journal of the American Psychiatric Association·Thomas R Insel, Philip S Wang
Mar 17, 2010·Mayo Clinic Proceedings·Robert H DworkinChristopher D Wells
Apr 21, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·N AttalT Nurmikko
Aug 14, 2010·Pain·Nanna Brix FinnerupTroels Staehelin Jensen
Oct 19, 2010·Nature Medicine·Vanja DuricRonald S Duman
Sep 6, 2011·Biological Psychiatry·Ipek YalcinMichel Barrot
Oct 15, 2011·Current Opinion in Cell Biology·Mounira BanasrRonald S Duman
Jun 19, 2012·Biological Psychiatry·Marije Aan Het RotSanjay J Mathew

❮ Previous
Next ❯


Feb 11, 2021·Chemical Research in Toxicology·Bonnie RobinsonJyotshna Kanungo
Apr 27, 2021·Frontiers in Psychiatry·Shengtao YangAmy F T Arnsten
May 6, 2021·Neuroscience and Biobehavioral Reviews·Sakina J RizviTim Salomons
May 31, 2021·Current Opinion in Anaesthesiology·Sabine Himmelseher, Eberhard F Kochs
Nov 28, 2021·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Shogo SatoRicardo Orozco-Solis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

British Journal of Anaesthesia
K Hirota, D G Lambert
JAMA Psychiatry
Samad E J Golzari, Ata Mahmoodpoor
JAMA Psychiatry
Christoph KrausSiegfried Kasper
© 2022 Meta ULC. All rights reserved